Hydroxychloroquine, hydroxycarbamide, and didanosine as economic treatment for HIV-1. (Q41917540)

14 October 2017

Hydroxychloroquine, hydroxycarbamide, and didanosine as economic treatment for HIV-1. (English)

1 reference

14 October 2017

1 reference

1 reference

1 reference

Nicholas I Paton

1

1 reference

14 October 2017

Jamila Aboulhab

series ordinal

2

1 reference

14 October 2017

Fatimah Karim

series ordinal

3

1 reference

14 October 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

14 October 2017

1 reference

14 October 2017

359

1 reference

14 October 2017

9318

1 reference

14 October 2017

1667-1668

1 reference

Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes

14 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908557-4

7 January 2021

Comparison of hydroxychloroquine with zidovudine in asymptomatic patients infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908557-4

7 January 2021

Chloroquine exerts an additive in vitro anti-HIV type 1 effect when associated with didanosine and hydroxyurea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908557-4

7 January 2021

The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908557-4

7 January 2021

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908557-4

7 January 2021

10.1016/S0140-6736(02)08557-4

Identifiers

DOI

1 reference

14 October 2017

1 reference